Test Bank for Pharmacotherapeutics for Advanced Practice Nurse Prescribers 4th Edition Woo Robinson

PHARMACOTHERAPEUTICS FOR ADVANCED M M


Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 4t
PRACTICE NURSE PRESCRIBERS,
M
h
M

4th EDITION
M
M M M

M
M

M
M

M




WOO ROBINSON
edition TESTBANK
Woo Robinson Test Bank
M M M M M M



PharmacotherapeuticsMforMAdvancedMPracticeMNurseMPrescribers,M4thMeditionMWooMRobinsonMTestMBank

ChapterM1.MTheMRoleMofMtheMNurseMPractitionerMasMPrescri

berMMultipleMChoice
IdentifyMtheMchoiceMthatMbestMcompletesMtheMstatementMorManswersMtheMquestion.

M M 1.MNurseMpractitionerMprescriptiveMauthorityMisMregulatedM by:
1. TheMNationalMCouncilMofMStateMBoardsMofMNursing
2. TheMU.S.MDrugMEnforcementMAdministration
3. TheMStateMBoardMofMNursingMforMeachMstate
4. TheMStateMBoardMofMPharmacy
M

M 2.MTheMbenefitsMtoMtheMpatientMofMhavingManMAdvancedMPracticeMRegisteredMNurseM(APR

N)MprescriberMinclude:
1. NursesMknowMmoreMaboutMPharmacologyMthanMotherMprescribersMbecauseMtheyMtak
eMitMbothMinMtheirMbasicMnursingMprogramMandMinMtheirMAPRNMprogram.
2. NursesMcareMforMtheMpatientMfromMaMholisticMapproachMandMincludeMtheMpatie
ntMinMdecisionMmakingMregardingMtheirMcare.
3. APRNsMareMlessMlikelyMtoMprescribeMnarcoticsMandMotherMcontrolledMsubstances.
4. APRNsMareMableMtoMprescribeMindependentlyMinMallMstates,MwhereasMaMphysici
an’sMassistantMneedsMtoMhaveMaMphysicianMsupervisingMtheirMpractice.
M M 3.MClinicalMjudgmentMinMprescribingMincludes:
1. FactoringMinMtheMcostMtoMtheMpatientMofMtheMmedicationMprescribed
2. AlwaysMprescribingMtheMnewestMmedicationMavailableMforMtheMdiseaseMprocess
3. HandingMoutMdrugMsamplesMtoMpoorMpatients
4. PrescribingMallMgenericMmedicationsMtoMcutMcosts
M M 4.MCriteriaMforMchoosingManMeffectiveMdrugMforMaMdisorderMinclude:
1. AskingMtheMpatientMwhatMdrugMtheyMthinkMwouldMworkMbestMforMthem
2. ConsultingMnationallyMrecognizedMguidelinesMforMdiseaseMmanagement
3. PrescribingMmedicationsMthatMareMavailableMasMsamplesMbeforeMwritingMaMprescription
4. FollowingMU.S.MDrugMEnforcementMAdministrationMguidelinesMforMprescribing
M M 5.MNurseMpractitionerMpracticeMmayMthriveMunderMhealth-careMreformMbecauseMof:
1. TheMdemonstratedMabilityMofMnurseMpractitionersMtoMcontrolMcostsMandMimproveMpat
ientMoutcomes
2. TheMfactMthatMnurseMpractitionersMwillMbeMableMtoMpracticeMindependently
3. TheMfactMthatMnurseMpractitionersMwillMhaveMfullMreimbursementMunderMhea
lth-McareMreform
4. TheMabilityMtoMshiftMaccountabilityMforMMedicaidMtoMtheMstateMlevel

, Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 4t
M M M M M M



hedition Woo Robinson Test Bank
M M M M M




ChapterM1.MTheMRoleMofMtheMNurseMPractitionerMasMPrescri
berMAnswerMSection

MULTIPLEMCHOICE

1.MANS: 3 PTS: 1
2.MANS: 2 PTS: 1
3.MANS: 1 PTS: 1
4.MANS: 2 PTS: 1
5.MANS: 1 PTS: 1

, Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 4t
M M M M M M



hedition Woo Robinson Test Bank
M M M M M




ChapterM2.MReviewMofMtheMBasicMPrinciplesMofMPharmacology

MultipleMChoice
IdentifyMtheMchoiceMthatMbestMcompletesMtheMstatementMorManswersMtheMquestion.

M

M 1.MAMpatient’sMnutritionalMintakeMandMlaboratoryMresultsMreflectMhypoalbuminemia.MThis

MisMcriticalMtoMprescribingMbecause:
1. DistributionMofMdrugsMtoMtargetMtissueMmayMbeMaffected.
2. TheMsolubilityMofMtheMdrugMwillMnotMmatchMtheMsiteMofMabsorption.
3. ThereMwillMbeMlessMfreeMdrugMavailableMtoMgenerateManMeffect.
4. DrugsMboundMtoMalbuminMareMreadilyMexcretedMbyMtheMkidneys.
M M 2.MDrugsMthatMhaveMaMsignificantMfirst-passM effect:
1. MustMbeMgivenMbyMtheMenteralM(oral)MrouteMonly
2. BypassMtheMhepaticMcirculation
3. AreMrapidlyMmetabolizedMbyMtheMliverMandMmayMhaveMlittleMifManyMdesiredMaction
4. AreMconvertedMbyMtheMliverMtoMmoreMactiveMandMfat-solubleMforms
M M 3.MTheMrouteMofMexcretionMofMaMvolatileMdrugMwillMlikelyMbeMthe:
1. Kidneys
2. Lungs
3. BileMandMfeces
4. Skin
M

M4.MMedroxyprogesteroneM(DepoMProvera)MisMprescribedMintramuscularlyM(IM)MtoMcre
ateMaMstorageMreservoirMofMtheMdrug.MStorageMreservoirs:
1. AssureMthatMtheMdrugMwillMreachMitsMintendedMtargetMtissue
2. AreMtheMreasonMforMgivingMloadingMdoses
3. IncreaseMtheMlengthMofMtimeMaMdrugMisMavailableMandMactive
4. AreMmostMcommonMinMcollagenMtissues
M M 5.MTheMNPMchoosesMtoMgiveMcephalexinMeveryM8MhoursMbasedMonMknowledgeMofMtheMdrug’s:
1. PropensityMtoMgoMtoMtheMtargetMreceptor
2. BiologicalMhalf-life
3. Pharmacodynamics
4. SafetyMandMsideMeffects

M

M6.MAzithromycinMdosingMrequiresMthatMtheMfirstMday’sMdosageMbeMtwiceMthoseMofMtheMother
M4MdaysMofMtheMprescription.MThisMisMconsideredMaMloadingMdose.MAMloadingMdose:
1. RapidlyMachievesMdrugMlevelsMinMtheMtherapeuticMrange
2. RequiresMfour-MtoMfive-half-livesMtoMattain
3. IsMinfluencedMbyMrenalMfunction
4. IsMdirectlyMrelatedMtoMtheMdrugMcirculatingMtoMtheMtargetMtissues
M

M 7.MTheMpointMinMtimeMonMtheMdrugMconcentrationMcurveMthatMindicatesMtheMfirstMsignMofMaMthe

rapeuticMeffectMisMthe:

, Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 4t
M M M M M M



hedition Woo Robinson Test Bank
M M M M M

1. MinimumMadverseMeffectMlevel
2. PeakMofMaction